Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: mitochondria derived peptides - CohBar

Next Previous
Drug Profile

Research programme: mitochondria derived peptides - CohBar

Alternative Names: CB-4209; Humanin - CohBar; MBTs - CohBar; MDPs - CohBar; Mitochondria-based therapeutics - CohBar; MOTS-c; MOTS-c analog - CohBar; SHLP 2; SHLP 6; Small humanin-like peptides - CohBar

Latest Information Update: 28 Feb 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Albert Einstein College of Medicine; University of Southern California
  • Developer Albert Einstein College of Medicine; CohBar; University of Southern California
  • Class Anti-ischaemics; Antidementias; Antihyperglycaemics; Antineoplastics; Cardiovascular therapies; Hepatoprotectants; Hormones; Neuroprotectants; Obesity therapies; Peptides; Vascular disorder therapies
  • Mechanism of Action Angiogenesis inhibitors; Apoptosis stimulants; Insulin receptor modulators; Lipolysis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Alzheimer's disease; Atherosclerosis; Cerebral ischaemia; Myocardial ischaemia; Neurodegenerative disorders; Non-alcoholic steatohepatitis; Obesity; Prostate cancer; Type 2 diabetes mellitus

Most Recent Events

  • 28 Feb 2021 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in USA
  • 28 Feb 2021 No recent reports of development identified for preclinical development in Obesity(Prevention) in USA
  • 28 Feb 2021 No recent reports of development identified for preclinical development in Prostate-cancer in USA
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top